Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (81-90 of 165) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|December 21, 2024
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registryMarc Thill, Mark-Oliver Zahn, Anja Welt, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus ConferenceMichael Untch, Peter A Fasching, Sara Y Brucker, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
International Journal of Cancer|March 18, 2026
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registryPatrick Marschner, Kai Ringwald, Marc Thill, et al.
Breast Care (Basel, Switzerland)|August 12, 2022
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus ConferenceCornelia Kolberg-Liedtke, Diana Lüftner, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion DiagnosticsDiana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert PanelTanja N Fehm, Elmar Stickeler, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|March 7, 2020
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known TherapiesAndreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
Cancers|October 1, 2020
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain MetastasesElena Laakmann, Isabell Witzel, Tanja Neunhöffer, et al.
Pageof 17

Showing results (81-90 of 165) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|December 21, 2024
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registryMarc Thill, Mark-Oliver Zahn, Anja Welt, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus ConferenceMichael Untch, Peter A Fasching, Sara Y Brucker, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
International Journal of Cancer|March 18, 2026
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registryPatrick Marschner, Kai Ringwald, Marc Thill, et al.
Breast Care (Basel, Switzerland)|August 12, 2022
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus ConferenceCornelia Kolberg-Liedtke, Diana Lüftner, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion DiagnosticsDiana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert PanelTanja N Fehm, Elmar Stickeler, Peter A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|March 7, 2020
Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known TherapiesAndreas Schneeweiss, Andreas D Hartkopf, Volkmar Müller, et al.
Geburtshilfe Und Frauenheilkunde|November 11, 2020
Update Breast Cancer 2020 Part 4 - Advanced Breast CancerHans Tesch, Volkmar Müller, Achim Wöckel, et al.
Cancers|October 1, 2020
Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain MetastasesElena Laakmann, Isabell Witzel, Tanja Neunhöffer, et al.
Pageof 17